Peter Lavin

3.0k total citations
30 papers, 827 citations indexed

About

Peter Lavin is a scholar working on Nephrology, Pathology and Forensic Medicine and Genetics. According to data from OpenAlex, Peter Lavin has authored 30 papers receiving a total of 827 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Nephrology, 5 papers in Pathology and Forensic Medicine and 5 papers in Genetics. Recurrent topics in Peter Lavin's work include Renal Diseases and Glomerulopathies (15 papers), Chronic Kidney Disease and Diabetes (5 papers) and Genetic and Kidney Cyst Diseases (4 papers). Peter Lavin is often cited by papers focused on Renal Diseases and Glomerulopathies (15 papers), Chronic Kidney Disease and Diabetes (5 papers) and Genetic and Kidney Cyst Diseases (4 papers). Peter Lavin collaborates with scholars based in Ireland, United States and United Kingdom. Peter Lavin's co-authors include Michelle P. Winn, Rasheed Gbadegesin, Peter J. Conlon, Andréy S. Shaw, Gentzon Hall, M. Ständer, Martin R. Pollak, Haiyang Yu, Jeffrey B. Kopp and Hani Suleiman and has published in prestigious journals such as Journal of Clinical Investigation, Kidney International and Journal of the American Society of Nephrology.

In The Last Decade

Peter Lavin

29 papers receiving 818 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Peter Lavin Ireland 14 570 300 149 138 121 30 827
Joshua A. Schwimmer United States 12 576 1.0× 237 0.8× 129 0.9× 66 0.5× 135 1.1× 19 861
Kazunori Inoue United States 14 566 1.0× 255 0.8× 61 0.4× 103 0.7× 84 0.7× 22 860
Jun Soma Japan 17 490 0.9× 247 0.8× 172 1.2× 68 0.5× 82 0.7× 64 961
Madhusudan Venkatareddy United States 12 639 1.1× 313 1.0× 57 0.4× 176 1.3× 39 0.3× 15 838
Silvia Berra Italy 10 229 0.4× 178 0.6× 89 0.6× 52 0.4× 64 0.5× 21 529
Davoud Mohtat United States 5 357 0.6× 412 1.4× 91 0.6× 121 0.9× 27 0.2× 6 778
Montserrat M. Díaz Encarnación Spain 15 238 0.4× 119 0.4× 63 0.4× 40 0.3× 44 0.4× 26 547
Beina Teng Germany 15 328 0.6× 232 0.8× 57 0.4× 88 0.6× 22 0.2× 21 579
Yoshiharu Muto Japan 15 233 0.4× 492 1.6× 92 0.6× 90 0.7× 25 0.2× 42 917
Christopher L. O’Connor United States 9 311 0.5× 375 1.3× 73 0.5× 70 0.5× 23 0.2× 17 725

Countries citing papers authored by Peter Lavin

Since Specialization
Citations

This map shows the geographic impact of Peter Lavin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Lavin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Lavin more than expected).

Fields of papers citing papers by Peter Lavin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter Lavin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Lavin. The network helps show where Peter Lavin may publish in the future.

Co-authorship network of co-authors of Peter Lavin

This figure shows the co-authorship network connecting the top 25 collaborators of Peter Lavin. A scholar is included among the top collaborators of Peter Lavin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter Lavin. Peter Lavin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Judge, Conor, Evelyn Deasy, Yvelynne P. Kelly, et al.. (2021). Exploring population pharmacokinetic models in patients treated with vancomycin during continuous venovenous haemodiafiltration (CVVHDF). Critical Care. 25(1). 443–443. 3 indexed citations
2.
Murray, Susan, Anthony Dorman, Katherine A. Benson, et al.. (2019). Utility of Genomic Testing after Renal Biopsy. American Journal of Nephrology. 51(1). 43–53. 19 indexed citations
3.
McKenna, Mary C., Michael E. Kelly, Gerard Boran, & Peter Lavin. (2019). Spectrum of rhabdomyolysis in an acute hospital. Irish Journal of Medical Science (1971 -). 188(4). 1423–1426. 10 indexed citations
4.
Cormican, Sarah, Dervla M. Connaughton, Claire Kennedy, et al.. (2019). Autosomal dominant tubulointerstitial kidney disease (ADTKD) in Ireland. Renal Failure. 41(1). 832–841. 14 indexed citations
5.
6.
Connaughton, Dervla M., Sarah I. Bukhari, Peter J. Conlon, et al.. (2015). The Irish Kidney Gene Project - Prevalence of Family History in Patients with Kidney Disease in Ireland. ˜The œNephron journals/Nephron journals. 130(4). 293–301. 36 indexed citations
7.
Hall, Gentzon, Rasheed Gbadegesin, Peter Lavin, et al.. (2014). A Novel Missense Mutation of Wilms’ Tumor 1 Causes Autosomal Dominant FSGS. Journal of the American Society of Nephrology. 26(4). 831–843. 41 indexed citations
8.
O’Shaughnessy, Michelle M., John O’Regan, & Peter Lavin. (2014). Prevention of Sudden Cardiac Death in Hemodialysis Patients. Cardiovascular & Haematological Disorders - Drug Targets. 14(3). 195–204. 1 indexed citations
9.
Malik, Talat H., Peter Lavin, Elena Goicoechea de Jorge, et al.. (2012). A Hybrid CFHR3-1 Gene Causes Familial C3 Glomerulopathy. Journal of the American Society of Nephrology. 23(7). 1155–1160. 99 indexed citations
10.
Akilesh, Shreeram, Hani Suleiman, Haiyang Yu, et al.. (2011). Arhgap24 inactivates Rac1 in mouse podocytes, and a mutant form is associated with familial focal segmental glomerulosclerosis. Journal of Clinical Investigation. 121(10). 4127–4137. 191 indexed citations
11.
Luo, Xiaoyan, Gentzon Hall, Songtao Li, et al.. (2011). Hepatorenal Correction in Murine Glycogen Storage Disease Type I With a Double-stranded Adeno-associated Virus Vector. Molecular Therapy. 19(11). 1961–1970. 27 indexed citations
12.
Gbadegesin, Rasheed, Peter Lavin, Gentzon Hall, et al.. (2011). Inverted formin 2 mutations with variable expression in patients with sporadic and hereditary focal and segmental glomerulosclerosis. Kidney International. 81(1). 94–99. 55 indexed citations
13.
Lavin, Peter, Elizabeth Finch, Jarrett Burch, et al.. (2011). TRPC6 Enhances Angiotensin II-induced Albuminuria. Journal of the American Society of Nephrology. 22(3). 526–535. 111 indexed citations
14.
Gbadegesin, Rasheed, Peter Lavin, John W. Foreman, & Michelle P. Winn. (2010). Pathogenesis and therapy of focal segmental glomerulosclerosis: an update. Pediatric Nephrology. 26(7). 1001–1015. 62 indexed citations
15.
Gbadegesin, Rasheed, Peter Lavin, Bartlomiej Bartkowiak, et al.. (2010). A New Locus for Familial FSGS on Chromosome 2P. Journal of the American Society of Nephrology. 21(8). 1390–1397. 4 indexed citations
16.
Lavin, Peter, Rasheed Gbadegesin, Tirupapuliyur V. Damodaran, & Michelle P. Winn. (2008). Therapeutic targets in focal and segmental glomerulosclerosis. Current Opinion in Nephrology & Hypertension. 17(4). 386–392. 16 indexed citations
17.
Gbadegesin, Rasheed, Bartlomiej Bartkowiak, Peter Lavin, et al.. (2008). Exclusion of homozygous PLCE1 (NPHS3) mutations in 69 families with idiopathic and hereditary FSGS. Pediatric Nephrology. 24(2). 281–285. 19 indexed citations
18.
Lavin, Peter, Patrick O’Kelly, F.J. Moloney, et al.. (2007). Improved Renal Allograft Survival with Vitamin D Receptor Polymorphism. Renal Failure. 29(7). 785–789. 12 indexed citations
19.
Malone, Andrew F., et al.. (2007). Mycobacterium tuberculosis in a renal transplant transmitted from the donor. Irish Journal of Medical Science (1971 -). 176(3). 233–235. 12 indexed citations
20.
Lavin, Peter. (2006). Object-Oriented PHP: Concepts, Techniques, and Code. CERN Document Server (European Organization for Nuclear Research). 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Joshua A. Schwimmer Breakdown of academic impact, for papers by Kazunori Inoue Breakdown of academic impact, for papers by Jun Soma Breakdown of academic impact, for papers by Madhusudan Venkatareddy Breakdown of academic impact, for papers by Silvia Berra Breakdown of academic impact, for papers by Davoud Mohtat Breakdown of academic impact, for papers by Montserrat M. Díaz Encarnación Breakdown of academic impact, for papers by Beina Teng Breakdown of academic impact, for papers by Yoshiharu Muto Breakdown of academic impact, for papers by Christopher L. O’Connor
Rankless by CCL
2026